DARPA (BTO): Medics Autonomously Stopping Hemorrhage (MASH)

MASH will mature the capability to autonomously perform hemorrhage control surgery for torso hemorrhage without an attending surgeon, but rather with a medic present to provide limited oversight and support.

Year 1: Bleed detection focus

Year 2: Bleed localization and end effector positioning focus

Year 3 (Phase II - Option Period): end-to-end workflow of performing hemostasis

Funding: no fixed limit 

Duration: 2 years + 1 year

Research Authority due date: n/a

Abstract (required) due date: 15.10.25

Full proposal due date: 25.11.25